Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1026 | 886 | 1026 | 1051 | 1381 | 2042 |
Fund Return | 2.56% | -11.38% | 2.56% | 1.68% | 6.66% | 7.4% |
Place in category | 253 | 609 | 253 | 25 | 47 | 53 |
% in Category | 22 | 62 | 22 | 2 | 9 | 15 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Balanced Fund A USD Acc | 8.94B | 13.66 | 2.10 | 6.98 | ||
Janus Balanced Fund I USD Acc | 8.94B | 14.83 | 3.15 | 8.03 | ||
Janus Global Life Sciences Fund A U | 4.02B | 1.72 | 0.86 | 6.56 | ||
Janus Global Technology Fund A USD | 527.64M | 31.48 | 7.25 | 17.00 | ||
Janus Global Technology Fund I USD | 527.64M | 32.58 | 8.14 | 17.96 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund A U | 4.02B | 1.72 | 0.86 | 6.56 | ||
Wellington Global Health Care EquUG | 2.22B | 5.66 | 1.88 | 8.04 | ||
Wellington Global Health Care EquiN | 2.22B | 5.18 | 1.37 | 7.49 | ||
Wellington Global Health Care EquiD | 2.08B | 4.56 | 0.72 | 6.80 | ||
Wellington Global Health Care EquiS | 2.08B | -2.69 | -2.90 | 6.48 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.97 | 870.37 | +3.35% | |
UnitedHealth | US91324P1021 | 6.61 | 530.04 | -1.81% | |
AstraZeneca | GB0009895292 | 3.66 | 11,786.0 | +5.93% | |
Novo Nordisk B | DK0062498333 | 3.66 | 635.0 | +2.50% | |
J&J | US4781601046 | 3.06 | 153.51 | -0.76% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review